Search

Simple Summary: Mastitis refers to the inflammation of the mammary parenchyma, caused by more than 136 microorganisms. It poses several challenges for farmers, veterinary clinicians, and researchers to understand and determine the most effective diagnostic tools and treatment protocols. This article discusses the clinical relevance, the causative pathogens, the economic factors involved, basic and advanced diagnostic techniques, and alternative therapeutic protocols required to control mastitis economically. There is a need to apply novel therapeutic technologies to overcome the challenges of traditional antibiotic-based therapies. These alternative therapeutic options could be supportive or additional options alongside conventional antibiotics-based therapies. Mastitis causes huge economic losses to dairy farmers worldwide, which largely negatively affects the quality and quantity of milk. Mastitis decreases overall milk production, degrades milk quality, increases milk losses because of milk being discarded, and increases overall production costs due to higher treatment and labour costs and premature culling. This review article discusses mastitis with respect to its clinical epidemiology, the pathogens involved, economic losses, and basic and advanced diagnostic tools that have been used in recent times to diagnose mastitis effectively. There is an increasing focus on the application of novel therapeutic approaches as an alternative to conventional antibiotic therapy because of the decreasing effectiveness of antibiotics, emergence of antibiotic-resistant bacteria, issue of antibiotic residues in the food chain, food safety issues, and environmental impacts. This article also discussed nanoparticles'/chitosan's roles in antibiotic-resistant strains and ethno-veterinary practices for mastitis treatment in dairy cattle. [ABSTRACT FROM AUTHOR]

Aim: To describe real-world testing patterns for RET in US patients with advanced/metastatic medullary thyroid cancer and determine consistency of real-world testing practices with national guidelines. Materials & methods: The authors performed a retrospective medical record analysis of patients with advanced/metastatic medullary thyroid cancer who initiated systemic therapy between 2013 and 2018. Seventy-five US-based oncologists collected the data using a customized electronic data collection form. Results: A total of 59.6% (121 of 203) of patients underwent testing for RET, and 37.2% (45 of 121) had a RET mutation, of which 55.6% were identified as RET mutation-positive before initial diagnosis. Overall, 90 (44.3%) patients were tested for biomarkers on or after initial diagnosis, with RET being the most tested (95.6%) biomarker. Conclusion: The authors' findings suggest an opportunity to improve testing rates in accordance with treatment guidelines. Mutations in the RET gene are common in patients with medullary thyroid cancer (MTC). As RET mutations are involved in the development of MTC, several treatment guidelines recommend counseling patients and testing for mutations in the RET gene in all patients with MTC. However, limited data are available on RET testing patterns in the USA in this patient population. In this study, the authors determined testing patterns for RET in patients with advanced or metastatic MTC in the USA using real-world data and found that only 60% of patients were tested for RET (i.e., testing for presence of RET mutations was observed in less than two-thirds of all patients included in the study). These results demonstrate the need for improved testing for RET mutations in patients with MTC in alignment with the treatment guidelines in routine clinical practice in the USA. [ABSTRACT FROM AUTHOR]

Mastitis causes huge economic losses to dairy farmers worldwide, which largely negatively affects the quality and quantity of milk. Mastitis decreases overall milk production, degrades milk quality, increases milk losses because of milk being discarded, and increases overall production costs due to higher treatment and labour costs and premature culling. This review article discusses mastitis with respect to its clinical epidemiology, the pathogens involved, economic losses, and basic and advanced diagnostic tools that have been used in recent times to diagnose mastitis effectively. There is an increasing focus on the application of novel therapeutic approaches as an alternative to conventional antibiotic therapy because of the decreasing effectiveness of antibiotics, emergence of antibiotic-resistant bacteria, issue of antibiotic residues in the food chain, food safety issues, and environmental impacts. This article also discussed nanoparticles’/chitosan’s roles in antibiotic-resistant strains and ethno-veterinary practices for mastitis treatment in dairy cattle.

Viral hepatitis (VH) is a significant public health issue with tremendous potential to aggravate into chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Recent decade has witnessed remarkable uprising in the drug development and effective treatment of VH. An upsurge is seen in identification of antiviral therapies with low rates of viral resistance, the improvement of Hepatitis B Virus (HBV) vaccination and the development of direct-acting antivirals for Hepatitis C Virus (HCV). But unfortunately, the "2030 worldwide eradication" objective of World Health Organization (WHO) is still unmet. It can be largely attributed to the deficit faced by the healthcare system concerning screening and diagnosis. A timely, accurate and comprehensive screening; encompassing maximum population coverage is essential to combat this disease. However, advancements in VH diagnostics remain inadequate and with a marginal use in routine practice. This paper deliberates upon the lacunae in traditional and prevailing diagnostic methodology of viral hepatitis, especially their inadequacy in meeting the unique situations prevailing low- and middle-income countries (LMIC). [ABSTRACT FROM AUTHOR]

Objectives: Its been long known that clinical appearance of healthy marginal periodontium differs from subject to subject and even different teeth type. Many features are directly genetically determined, others seem to be influenced by size, shape and position. Hence in this study, the relationship between the different teeth type and the thickness of gingiva was examined. Methods : Thirty two systemically healthy patients, devoid of symptoms of destructive periodontal disease (16 males and 16 females) participated in this study. Gingival thickness was assessed in the maxillary and mandibular anteriors by ultrasonographic method (USG). Results: It was observed that thickness of gingiva varied in the central incisor, lateral incisor and canine. Conclusion: It was concluded that thickness of gingiva varies with the different teeth type and USG method assess the gingival thickness accurately and rapidly.

Abstract: Contemporary Chinese pulse diagnosis™ (CCPD) is a system of pulse diagnosis utilized by Dr. John He Feng Shen, OMD, and documented by Dr. Leon Hammer, MD, in the book Chinese Pulse Diagnosis, A Contemporary Approach. It is the traditional method of the Ding medical lineage from the Shanghai region and dates to the 15th century in Chinese language texts. The fundamentals of this system are, however, much older and can be directly traced to the Neijing Suwen. Having been passed from the last direct inheritor of Ding knowledge (Dr. Shen) to modern practitioners of Chinese medicine by way of Dr. Hammer and his students, it represents an important system of advanced diagnosis. Although modern diagnostic technology provides very sophisticated diagnoses, for these instruments to be effective, the disease process must already have a physical manifestation. CCPD, on the other hand, provides the earliest warnings of physiological processes, which if left unchecked may result in the subsequent appearance of a disease. This article describes the derivation and the principles of this system of pulse diagnosis and explores its successful integration into the modern practice of Chinese medicine. [Copyright &y& Elsevier]